The numbers are startling. The implications are massive. But it has barely registered as a whisper. Data from the American Heart Association is among the most trusted healthcare data in the world. And this data makes it very clear – a massive epidemic of cardiovascular deaths began in the United States in 2011 and, apparently at least, ended in 2023. As the reader can clearly see for themselves, deaths from cardiovascular diseases had been steadily decreasing in the United States since the 1970s. Then, in 2011, we see a massive surge in cardiovascular deaths, deaths clearly not associated with COVID (COVID began March of 2020, 9 years later). The most recent data from 2023 seems to suggest that this epidemic of massive proportions appears to be over. This would raise the prospect of an extinction event of a vulnerable subpopulation within the United States. This event was of such massive proportions that US life expectancy was seen to stall.
Executive Director of Smith Genetics Research, Douglas Smith, MD is quoted as saying, “This is a deadly failure of the public health system represented by HHS. Perhaps before former Cabinet Secretary Becerra runs for Governor of California, some basic questions regarding this epidemic and his role as Secretary of HHS should be answered. Our extrapolation of the cardiovascular death data from the American Heart Association suggests that approximately 4 million died during this epidemic. This would be the equivalent of the entire state of Oklahoma suddenly dying of a catastrophic cardiovascular event. The American public deserve answers. The families of those lost deserve answers”. It should be noted that in his upcoming book, The Pharmaceutical Genocide, Dr. Smith has put forth the hypothesis that these cardiovascular deaths are linked to DNA methylation caused by the opioids. The FDA currently does not require pharmaceutical companies to undergo any type of evaluation for methylation toxicity due to a drug. Further information can be found at Smith Genetics Research .
